Toggle Main Menu Toggle Search

ePrints

Browsing publications by Peter Curtis

Newcastle AuthorsTitleYearFull text
Professor Georg Lietz
Peter Curtis
Professor John Mathers
Dr Franck Tourniaire
CD36 and SR-BI Are Involved in Cellular Uptake of Provitamin A Carotenoids by Caco-2 and HEK Cells, and Some of Their Genetic Variants Are Associated with Plasma Concentrations of These Micronutrients in Humans2013
Peter Curtis
Professor Georg Lietz
Professor John Mathers
Apolipoprotein E genotype and the cardiovascular disease risk phenotype: Impact of sex and adiposity (the FINGEN study)2012
Peter Curtis
Professor Ashley Adamson
Professor John Mathers
Effects on nutrient intake of a family-based intervention to promote increased consumption of low-fat starchy foods through education, cooking skills and personalised goal setting: the Family Food and Health Project2012
Professor Georg Lietz
Peter Curtis
Julie Stannard
Professor John Mathers
Effect of sex and genotype on cardiovascular biomarker response to fish oils: the FINGEN Study2008
Peter Curtis
Professor Philip Home
Effect of the addition of rosiglitazone to metformin or sulfonylureas versus metformin/sulfonylurea combination therapy on ambulatory blood pressure in people with type 2 diabetes: A randomized controlled trial (the RECORD study)2008
Professor Philip Home
Peter Curtis
Rosiglitazone RECORD study: Glucose control outcomes at 18 months2007
Professor Philip Home
Peter Curtis
[abstract] Prolonged efficacity on 12 months of rosiglitazone given in association on ambulatory arterial stiffness in patients suffering type 2 diabetes2006
Peter Curtis
Professor Philip Home
Randomized controlled trial of the effect of rosiglitazone in combination therapy on ambulatory blood pressure in people with type 2 diabetes mellitus followed for 12 months2005
Peter Curtis
Professor Philip Home
Rosiglitazone combination therapy lowers ambulatory blood pressure (ABP) over a twelve month period in patients with Type 2 diabetes mellitus2005
Professor Philip Home
Peter Curtis
Rosiglitazone combination therapy improves ambulatory blood pressure: A 6-month substudy of the RECORD trial in people with type 2 diabetes2004
12